Baidu
map

风湿免疫科指南

订阅

MedSci主页 / 所有栏目 / 风湿免疫科指南

2020 BSR指南：巨细胞动脉炎的诊断和治疗

2020-01-23 英国风湿病学会 Rheumatology (Oxford). 2020 Jan 23.

巨细胞动脉炎

2020年1月，英国风湿病学会(BSR)发布了巨细胞动脉炎的诊断和治疗指南，巨细胞动脉炎（GCA）一种影响老年人群的大血管炎，在70-79岁人群中发病率最高。本文的主要目的是针对GCA的诊断和治疗提供指导建议。

中文标题：

2020 BSR指南：巨细胞动脉炎的诊断和治疗

英文标题：

British Society for Rheumatology guideline on diagnosis and treatment of giant cell arteritis.

发布机构：

英国风湿病学会

发布日期：

2020-01-23

简要介绍：

2020年1月，英国风湿病学会(BSR)发布了巨细胞动脉炎的诊断和治疗指南，巨细胞动脉炎（GCA）一种影响老年人群的大血管炎，在70-79岁人群中发病率最高。本文的主要目的是针对GCA的诊断和治疗提供指导建议。

 

拓展指南：与动脉炎相关指南：

相关资料下载：
[AttachmentFileName(sort=100, fileName=2020 BSR指南：巨细胞动脉炎的诊断和治疗)] GetToolGuiderByIdResponse(projectId=1, id=128f71c0018602bf, title=2020 BSR指南：巨细胞动脉炎的诊断和治疗, enTitle=British Society for Rheumatology guideline on diagnosis and treatment of giant cell arteritis., guiderFrom=Rheumatology (Oxford). 2020 Jan 23., authorId=null, author=, summary=2020年1月，英国风湿病学会(BSR)发布了巨细胞动脉炎的诊断和治疗指南，巨细胞动脉炎（GCA）一种影响老年人群的大血管炎，在70-79岁人群中发病率最高。本文的主要目的是针对GCA的诊断和治疗提供指导建议。 , cover=, journalId=null, articlesId=null, associationId=442, associationName=英国风湿病学会, associationIntro=BSR promotes excellence in the treatment of people with arthritis and musculoskeletal conditions and supports those delivering it. We have over 25 years of expertise in promoting high quality standards of care, providing education, training and support to those working in rheumatology. We have more than 1,500 members including rheumatologists, scientists, trainees, allied health professionals and others from the UK and overseas., copyright=0, guiderPublishedTime=Thu Jan 23 00:00:00 CST 2020, originalUrl=, linkOutUrl=, content=<P>2020年1月，英国风湿病学会(BSR)发布了巨细胞动脉炎的诊断和治疗指南，巨细胞动脉炎（GCA）一种影响老年人群的大血管炎，在70-79岁人群中发病率最高。本文的主要目的是针对GCA的诊断和治疗提供指导建议。 </P> <P> </P>拓展指南：<strong>与<font color=red>动脉炎</font>相关指南：</strong><br><ul><li><a href="//m.sandwebs.com/guideline/show_article.do?id=3a3f11c001829322" title="中国大动脉炎性肾动脉炎诊治多学科专家共识" target=_blank>中国大动脉炎性肾动脉炎诊治多学科专家共识</a></li> <li><a href="//m.sandwebs.com/guideline/show_article.do?id=c0f131c001e232fa" title="2018 EULAR建议：支持巨细胞动脉炎观察研究及临床护理的核心数据集" target=_blank>2018 EULAR建议：支持巨细胞动脉炎观察研究及临床护理的核心数据集</a></li> <li><a href="//m.sandwebs.com/guideline/show_article.do?id=a20501c000838016" title="2011 风湿性多肌痛和巨细胞动脉炎诊断和治疗指南" target=_blank>2011 风湿性多肌痛和巨细胞动脉炎诊断和治疗指南</a></li> <li><a href="//m.sandwebs.com/guideline/show_article.do?id=a92361c000825363" title="2011 中国 结节性多动脉炎诊断和治疗指南" target=_blank>2011 中国 结节性多动脉炎诊断和治疗指南</a></li> <li><a href="//m.sandwebs.com/guideline/show_article.do?id=92de31c000816eaa" title="2011 大动脉炎诊断及治疗指南" target=_blank>2011 大动脉炎诊断及治疗指南</a></li> 更多信息请点击：<a href="//m.sandwebs.com/guideline/list.do?q=%E5%8A%A8%E8%84%89%E7%82%8E" target=_blank>有关动脉炎更多指南</a></ul>, tagList=[TagDto(tagId=11683, tagName=巨细胞动脉炎)], categoryList=[CategoryDto(categoryId=15, categoryName=风湿免疫科, tenant=100), CategoryDto(categoryId=21100, categoryName=达仁堂循证e学界, tenant=100)], articleKeywordId=null, articleKeyword=null, articleKeywordNum=null, guiderKeywordId=null, guiderKeyword=null, guiderKeywordNum=null, haveAttachments=1, attachmentList=null, guiderType=0, guiderArea=指南, guiderLanguage=0, guiderRegion=0, opened=0, paymentType=null, paymentAmount=10, recommend=0, recommendEndTime=null, sticky=0, stickyEndTime=null, allHits=7192, appHits=205, showAppHits=5, pcHits=4011, showPcHits=4823, likes=32, shares=9, comments=5, approvalStatus=1, publishedTime=Tue Feb 04 22:03:41 CST 2020, publishedTimeString=2020-01-23, pcVisible=1, appVisible=1, editorId=2020535, editor=qiushida2, waterMark=0, formatted=0, memberCards=[], isPrivilege=0, deleted=0, version=1, createdBy=null, createdName=qiushida2, createdTime=Tue Feb 04 22:03:41 CST 2020, updatedBy=null, updatedName=null, updatedTime=Fri Jan 05 11:54:33 CST 2024, courseDetails=[], otherVersionGuiders=[], isGuiderMember=false, ipAttribution=, attachmentFileNameList=[AttachmentFileName(sort=100, fileName=2020 BSR指南：巨细胞动脉炎的诊断和治疗)])
2020 BSR指南：巨细胞动脉炎的诊断和治疗
下载请点击：
评论区 (5)
#插入话题
  1. [GetPortalCommentsPageByObjectIdResponse(id=1070996, encodeId=ea3b10e0996ec, content=优秀, beContent=null, objectType=guider, channel=null, level=null, likeNumber=89, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=fe965645581, createdName=ms5000001580951979, createdTime=Wed Nov 17 08:59:43 CST 2021, time=2021-11-17, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1070995, encodeId=9cfb10e0995c2, content=积分, beContent=null, objectType=guider, channel=null, level=null, likeNumber=95, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=fe965645581, createdName=ms5000001580951979, createdTime=Wed Nov 17 08:59:30 CST 2021, time=2021-11-17, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1061167, encodeId=f0db106116e75, content=好, beContent=null, objectType=guider, channel=null, level=null, likeNumber=137, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=3c345506157, createdName=医学小朋友, createdTime=Sun Oct 17 08:00:29 CST 2021, time=2021-10-17, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=963476, encodeId=25969634e661, content=积分, beContent=null, objectType=guider, channel=null, level=null, likeNumber=96, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=841b5288739, createdName=hyqcwx, createdTime=Fri May 07 20:25:58 CST 2021, time=2021-05-07, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=903737, encodeId=761f903e3739, content=好, beContent=null, objectType=guider, channel=null, level=null, likeNumber=127, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=839d3031997, createdName=yuanfannny, createdTime=Tue Dec 01 06:03:57 CST 2020, time=2020-12-01, status=1, ipAttribution=)]
    2021-11-17 ms5000001580951979

    优秀

    0

  2. [GetPortalCommentsPageByObjectIdResponse(id=1070996, encodeId=ea3b10e0996ec, content=优秀, beContent=null, objectType=guider, channel=null, level=null, likeNumber=89, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=fe965645581, createdName=ms5000001580951979, createdTime=Wed Nov 17 08:59:43 CST 2021, time=2021-11-17, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1070995, encodeId=9cfb10e0995c2, content=积分, beContent=null, objectType=guider, channel=null, level=null, likeNumber=95, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=fe965645581, createdName=ms5000001580951979, createdTime=Wed Nov 17 08:59:30 CST 2021, time=2021-11-17, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1061167, encodeId=f0db106116e75, content=好, beContent=null, objectType=guider, channel=null, level=null, likeNumber=137, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=3c345506157, createdName=医学小朋友, createdTime=Sun Oct 17 08:00:29 CST 2021, time=2021-10-17, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=963476, encodeId=25969634e661, content=积分, beContent=null, objectType=guider, channel=null, level=null, likeNumber=96, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=841b5288739, createdName=hyqcwx, createdTime=Fri May 07 20:25:58 CST 2021, time=2021-05-07, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=903737, encodeId=761f903e3739, content=好, beContent=null, objectType=guider, channel=null, level=null, likeNumber=127, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=839d3031997, createdName=yuanfannny, createdTime=Tue Dec 01 06:03:57 CST 2020, time=2020-12-01, status=1, ipAttribution=)]
    2021-11-17 ms5000001580951979

    积分

    0

  3. [GetPortalCommentsPageByObjectIdResponse(id=1070996, encodeId=ea3b10e0996ec, content=优秀, beContent=null, objectType=guider, channel=null, level=null, likeNumber=89, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=fe965645581, createdName=ms5000001580951979, createdTime=Wed Nov 17 08:59:43 CST 2021, time=2021-11-17, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1070995, encodeId=9cfb10e0995c2, content=积分, beContent=null, objectType=guider, channel=null, level=null, likeNumber=95, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=fe965645581, createdName=ms5000001580951979, createdTime=Wed Nov 17 08:59:30 CST 2021, time=2021-11-17, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1061167, encodeId=f0db106116e75, content=好, beContent=null, objectType=guider, channel=null, level=null, likeNumber=137, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=3c345506157, createdName=医学小朋友, createdTime=Sun Oct 17 08:00:29 CST 2021, time=2021-10-17, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=963476, encodeId=25969634e661, content=积分, beContent=null, objectType=guider, channel=null, level=null, likeNumber=96, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=841b5288739, createdName=hyqcwx, createdTime=Fri May 07 20:25:58 CST 2021, time=2021-05-07, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=903737, encodeId=761f903e3739, content=好, beContent=null, objectType=guider, channel=null, level=null, likeNumber=127, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=839d3031997, createdName=yuanfannny, createdTime=Tue Dec 01 06:03:57 CST 2020, time=2020-12-01, status=1, ipAttribution=)]
    2021-10-17 医学小朋友

    好

    0

  4. [GetPortalCommentsPageByObjectIdResponse(id=1070996, encodeId=ea3b10e0996ec, content=优秀, beContent=null, objectType=guider, channel=null, level=null, likeNumber=89, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=fe965645581, createdName=ms5000001580951979, createdTime=Wed Nov 17 08:59:43 CST 2021, time=2021-11-17, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1070995, encodeId=9cfb10e0995c2, content=积分, beContent=null, objectType=guider, channel=null, level=null, likeNumber=95, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=fe965645581, createdName=ms5000001580951979, createdTime=Wed Nov 17 08:59:30 CST 2021, time=2021-11-17, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1061167, encodeId=f0db106116e75, content=好, beContent=null, objectType=guider, channel=null, level=null, likeNumber=137, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=3c345506157, createdName=医学小朋友, createdTime=Sun Oct 17 08:00:29 CST 2021, time=2021-10-17, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=963476, encodeId=25969634e661, content=积分, beContent=null, objectType=guider, channel=null, level=null, likeNumber=96, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=841b5288739, createdName=hyqcwx, createdTime=Fri May 07 20:25:58 CST 2021, time=2021-05-07, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=903737, encodeId=761f903e3739, content=好, beContent=null, objectType=guider, channel=null, level=null, likeNumber=127, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=839d3031997, createdName=yuanfannny, createdTime=Tue Dec 01 06:03:57 CST 2020, time=2020-12-01, status=1, ipAttribution=)]
    2021-05-07 hyqcwx

    积分

    0

  5. [GetPortalCommentsPageByObjectIdResponse(id=1070996, encodeId=ea3b10e0996ec, content=优秀, beContent=null, objectType=guider, channel=null, level=null, likeNumber=89, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=fe965645581, createdName=ms5000001580951979, createdTime=Wed Nov 17 08:59:43 CST 2021, time=2021-11-17, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1070995, encodeId=9cfb10e0995c2, content=积分, beContent=null, objectType=guider, channel=null, level=null, likeNumber=95, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=fe965645581, createdName=ms5000001580951979, createdTime=Wed Nov 17 08:59:30 CST 2021, time=2021-11-17, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1061167, encodeId=f0db106116e75, content=好, beContent=null, objectType=guider, channel=null, level=null, likeNumber=137, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=3c345506157, createdName=医学小朋友, createdTime=Sun Oct 17 08:00:29 CST 2021, time=2021-10-17, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=963476, encodeId=25969634e661, content=积分, beContent=null, objectType=guider, channel=null, level=null, likeNumber=96, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=841b5288739, createdName=hyqcwx, createdTime=Fri May 07 20:25:58 CST 2021, time=2021-05-07, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=903737, encodeId=761f903e3739, content=好, beContent=null, objectType=guider, channel=null, level=null, likeNumber=127, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=839d3031997, createdName=yuanfannny, createdTime=Tue Dec 01 06:03:57 CST 2020, time=2020-12-01, status=1, ipAttribution=)]
    2020-12-01 yuanfannny

    好

    0

相关指南

2018 EULAR建议：支持巨细胞动脉炎观察研究及临床护理的核心数据集

欧洲抗风湿病联盟(EULAR,The European League Against Rheumatism) · 2019-03-21

Baidu
map
Baidu
map
Baidu
map